Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-01

Clinical Trial Update: Haloperidol for the Treatment of Nausea and Vomiting in the ED [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating haloperidol for nausea and vomiting in the emergency department has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Western Michigan University School of Medicine | Conditions: Vomiting, Nausea | Phase 4 | Status: COMPLETED